NO321606B1 - Pyrrolderivater og medisinsk sammensetning - Google Patents

Pyrrolderivater og medisinsk sammensetning Download PDF

Info

Publication number
NO321606B1
NO321606B1 NO19975666A NO975666A NO321606B1 NO 321606 B1 NO321606 B1 NO 321606B1 NO 19975666 A NO19975666 A NO 19975666A NO 975666 A NO975666 A NO 975666A NO 321606 B1 NO321606 B1 NO 321606B1
Authority
NO
Norway
Prior art keywords
substituted
hydrogen
cyano
compound
pollakiuria
Prior art date
Application number
NO19975666A
Other languages
English (en)
Norwegian (no)
Other versions
NO975666L (no
NO975666D0 (no
Inventor
Masami Tsuda
Mitsushi Tanaka
Ayatsugu Nakamura
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of NO975666D0 publication Critical patent/NO975666D0/no
Publication of NO975666L publication Critical patent/NO975666L/no
Publication of NO321606B1 publication Critical patent/NO321606B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19975666A 1995-06-07 1997-12-05 Pyrrolderivater og medisinsk sammensetning NO321606B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14069895 1995-06-07
PCT/JP1996/001526 WO1996040634A1 (fr) 1995-06-07 1996-06-06 Derives du pyrrole et composition medicamenteuse les renfermant

Publications (3)

Publication Number Publication Date
NO975666D0 NO975666D0 (no) 1997-12-05
NO975666L NO975666L (no) 1998-02-09
NO321606B1 true NO321606B1 (no) 2006-06-12

Family

ID=15274666

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975666A NO321606B1 (no) 1995-06-07 1997-12-05 Pyrrolderivater og medisinsk sammensetning

Country Status (20)

Country Link
US (2) US5998459A (ko)
EP (1) EP0842923B1 (ko)
JP (1) JP3160910B2 (ko)
KR (1) KR100275222B1 (ko)
CN (2) CN1090617C (ko)
AT (1) ATE318799T1 (ko)
AU (1) AU710683B2 (ko)
BR (1) BR9608502A (ko)
CA (1) CA2223918C (ko)
DE (1) DE69635857T2 (ko)
DK (1) DK0842923T3 (ko)
ES (1) ES2259795T3 (ko)
HU (1) HUP9802290A3 (ko)
MX (1) MX9709475A (ko)
NO (1) NO321606B1 (ko)
NZ (1) NZ309151A (ko)
PT (1) PT842923E (ko)
RU (1) RU2166941C2 (ko)
TW (1) TW504503B (ko)
WO (1) WO1996040634A1 (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2166941C2 (ru) * 1995-06-07 2001-05-20 Ниппон Синяку Ко., Лтд. Производные пиррола и фармацевтическая композиция на их основе
KR100485642B1 (ko) * 1996-03-18 2005-09-30 에자이 가부시키가이샤 축합고리함유카르복실산유도체
ATE295166T1 (de) * 1998-01-14 2005-05-15 Nippon Shinyaku Co Ltd Aktivatoren der kalium-kanäle
WO1999061016A1 (en) * 1998-05-27 1999-12-02 Nippon Shinyaku Co., Ltd. Cyclooxygenase-2 inhibitors
EP1283040A4 (en) * 2000-03-21 2008-05-14 Nippon Shinyaku Co Ltd ORAL PREPARATIONS WITH PROLONGED RELEASE
AU2001278875B2 (en) * 2000-07-06 2007-06-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Tetrahydrobenzothiazole analogues as neuroprotective agents
TWI239952B (en) * 2001-03-14 2005-09-21 Nippon Shinyaku Co Ltd Stable crystals of pyrrole compound
NZ529043A (en) * 2001-04-16 2006-11-30 Tanabe Seiyaku Co Large conductance calcium-activated K channel opener
TWI271402B (en) * 2002-10-15 2007-01-21 Tanabe Seiyaku Co Large conductance calcium-activated K channel opener
ATE450530T1 (de) * 2003-03-13 2009-12-15 Vertex Pharma Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
US20050075359A1 (en) * 2003-03-14 2005-04-07 Rikako Kono Large conductance calcium-activated K channel opener
GB0321509D0 (en) * 2003-09-13 2003-10-15 Astrazeneca Ab Chemical compounds
EP1675585A2 (en) * 2003-10-17 2006-07-05 Tanabe Seiyaku Co., Ltd. Large conductance calcium-activated k channel opener
US7118801B2 (en) * 2003-11-10 2006-10-10 Gore Enterprise Holdings, Inc. Aerogel/PTFE composite insulating material
ITTO20040125A1 (it) * 2004-03-01 2004-06-01 Rotta Research Lab Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica
JP2005325103A (ja) * 2004-04-13 2005-11-24 Tanabe Seiyaku Co Ltd 医薬組成物
US7880008B2 (en) * 2005-05-31 2011-02-01 Vertex Pharmaceuticals Incorporated Heterocycles useful as modulators of ion channels
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070404A1 (es) * 2005-07-29 2007-05-10 Wyeth Corp Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona
TW200948362A (en) 2008-04-09 2009-12-01 Mitsubishi Tanabe Pharma Corp New compounds and their uses
BR112017012588B8 (pt) 2014-12-17 2024-03-05 King S College London Compostos heteroaril-heteroarila bicíclicos de ácido benzoico, seus usos, composições farmacêuticas, métodos de preparação destas e métodos para provocar ou promover o desenvolvimento de neuritos, o crescimento de neuritos e/ou a regeneração de neuritos e para ativar o receptor beta do ácido retinoico
GB201610867D0 (en) 2016-06-22 2016-08-03 King's College London Crystalline forms of a therapeutic compound and processes for their preparation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD143426A1 (de) * 1979-05-07 1980-08-20 Karl Gewald Verfahren zur herstellung von 5,6-kondensierten 4-amino-3-cyan-pyridonen-(2)
US4431823A (en) * 1981-07-23 1984-02-14 Hoffmann-La Roche Inc. 1H-Pyrrole-3-carbonitrile-4(2-benzoyl)phenyl derivatives as intermediates for pyrrolo[3,4-D][2]benzazepines
FR2569189B1 (fr) * 1984-08-14 1986-12-19 Roussel Uclaf Nouveaux derives du pyrrole, leur procede de preparation et leur application comme pesticides
IL87222A (en) * 1987-07-29 1993-04-04 American Cyanamid Co Arylpyrroles, methods for thepreparation thereof andinsecticidal, acaricidal andnematicidal compositionscontaining them
US4929634A (en) * 1987-10-23 1990-05-29 American Cyanamid Company Method of and bait compositions for controlling mollusks
US4886625A (en) * 1987-10-29 1989-12-12 Miles Inc. Functionalized conducting polymers and their use in diagnostic devices
DE3820190A1 (de) * 1988-06-14 1989-12-21 Cassella Ag Pyrrolderivate, ihre herstellung und ihre verwendung als pharmazeutische wirkstoffe
EP0358047A3 (en) * 1988-09-08 1991-05-29 American Cyanamid Company Method of controlling phytopathogenic fungi
US5021586A (en) * 1989-03-31 1991-06-04 Miles, Inc. Dithiophenylpyrrole derivative monomers for preparing semi-conducting polymers
US5210092A (en) * 1990-09-25 1993-05-11 Fujisawa Pharmaceutical Co., Ltd. Angiotensin ii antagonizing heterocyclic derivatives
WO1993019067A1 (en) * 1991-09-12 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine derivatives as angiotensin ii antagonists
FR2698364B1 (fr) * 1992-11-24 1995-01-27 Synthelabo Dérivés de pyrrole, leur préparation et leur application en thérapeutique.
FR2706899A1 (en) * 1993-06-22 1994-12-30 Synthelabo Pyrrole derivatives, their preparation and their therapeutic application
US5359090A (en) * 1993-12-29 1994-10-25 American Cyanamid Company Alkoxymethylation of pyrroles
RU2166941C2 (ru) * 1995-06-07 2001-05-20 Ниппон Синяку Ко., Лтд. Производные пиррола и фармацевтическая композиция на их основе

Also Published As

Publication number Publication date
US6172102B1 (en) 2001-01-09
EP0842923B1 (en) 2006-03-01
CA2223918C (en) 2006-01-10
HUP9802290A3 (en) 2002-02-28
AU5910996A (en) 1996-12-30
CN1349796A (zh) 2002-05-22
EP0842923A1 (en) 1998-05-20
KR100275222B1 (ko) 2001-02-01
JP3160910B2 (ja) 2001-04-25
PT842923E (pt) 2006-07-31
WO1996040634A1 (fr) 1996-12-19
US5998459A (en) 1999-12-07
ATE318799T1 (de) 2006-03-15
MX9709475A (es) 1998-02-28
NZ309151A (en) 2000-01-28
ES2259795T3 (es) 2006-10-16
DE69635857D1 (de) 2006-04-27
CA2223918A1 (en) 1996-12-19
HUP9802290A2 (hu) 1999-10-28
NO975666L (no) 1998-02-09
RU2166941C2 (ru) 2001-05-20
EP0842923A4 (en) 1999-12-29
KR19990022329A (ko) 1999-03-25
CN1090617C (zh) 2002-09-11
BR9608502A (pt) 1999-07-06
AU710683B2 (en) 1999-09-30
DK0842923T3 (da) 2006-06-19
TW504503B (en) 2002-10-01
DE69635857T2 (de) 2006-10-19
CN1186485A (zh) 1998-07-01
NO975666D0 (no) 1997-12-05

Similar Documents

Publication Publication Date Title
NO321606B1 (no) Pyrrolderivater og medisinsk sammensetning
AU738743B2 (en) Antipruritic
ES2293993T3 (es) Inhibidores de produccion de tnf-alfa.
KR20090034395A (ko) 운데카프레닐 피로포스페이트 합성효소의 억제제
CN104662007A (zh) 胱硫醚-γ-裂合酶(CSE)抑制剂
WO2020035040A1 (zh) 3-芳氧基-3-五元杂芳基-丙胺类化合物及其用途
NO144210B (no) Analogifremgangsmaate til fremstilling av nye dl-tyrosinderivater med farmasoeytisk virkning paa glatte muskler
HU226976B1 (en) Use of pirrolidine derivatives having kappa-opium-agonist effect for the preparation of a medicament for treating of inflammatory diseases of the intestine
JP2010521516A (ja) 疼痛および過敏性腸症候群の治療におけるキノリン誘導体の使用
CN115304593B (zh) 苯并异噻唑化合物及其药物组合物和应用
CN115304590B (zh) 2h-苯并三氮唑衍生物及其制备方法及含有它们的药物组合物
AU2003228991B2 (en) Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
AU2016253911A1 (en) Carboxylic acid URAT1 inhibitor containing diarylmethane structure, preparation method and use thereof
JP2002053566A (ja) チアゾール化合物及びその医薬用途
CA3119313A1 (en) Pharmaceutical composition comprising histone deacetylase 6 inhibitors
ES2213205T3 (es) Uso de antagonistas del receptor 5-ht1a para el tratamiento de la incontinencia de orina.
PL187691B1 (pl) Nowa postać N-metylo-N-{(1S)-1-fenylo-2-[(3S)-3-hydroksypirolidyn-1-ylo]etylo}-2,2-difenyloacetamidu, jego zastosowanie i sposób wytwarzania
TWI721697B (zh) 用於治療骨關節炎的化合物
US4492698A (en) Diphenylbutyl-1-acylpiperazines
JP2021525269A (ja) 疼痛処置のための化合物、それを含む組成物及びそれを使用する方法
US20080242657A1 (en) Treatment of Tremor with Histamine H3 Inverse Agonists or Hist Amine H3 Antagonists
JPH04225917A (ja) 記憶増強剤として有用な５−アリ−ル−４−アルキル−３ｈ−１，２，４−トリアゾール−３−チオン類
CN109879840B (zh) 4-哌嗪甲基-7-羟基苯并呋喃类化合物及其医药用途
ES2292636T3 (es) 1-(2-m-metanosulfanomidofeniletil)-4-(m-trifluorometilfenil)piper.
CN100427089C (zh) 吲唑衍生物用于制备治疗神经病性疼痛药物的用途